Numinus Files U.S. Provisional Patent Application for a Proprietary Rapid Production Process for Psilocybe and Other Psychoactive Fungi Species
"At Numinus, one of the key goals of our lab's research and discovery work is to support accessibility to psychedelic-assisted psychotherapies," said Sharan Sidhu, Numinus Bioscience General Manager and Science Officer.
- "At Numinus, one of the key goals of our lab's research and discovery work is to support accessibility to psychedelic-assisted psychotherapies," said Sharan Sidhu, Numinus Bioscience General Manager and Science Officer.
- "The rapid production process announced today meets that goal by enhancing our ability to seamlessly formulate safe and effective products with consistent psychoactive properties at scale, with the regulatory confidence that comes with standardized products."
- Numinus initially tested the production process to rapidly generate a Psilocybe species extract as 'proof of concept'.
- Results revealed a highly efficient, scalable process that can be applied to other species of psychoactive fungi.